Julie Rubinstein

President and COO

Julie Rubinstein (President and COO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$13.2M

shares × price, as filed

Last traded

Apr 27

Filed Apr 29

Median ADV $72.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $13.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

ADPT

Adaptive Biotechnologies Corporation ADPT · 0 buys · 15 sells 15 filings

Recent filings

ADPTSALE Adaptive Biotechnologies Corporation View filing → $802K
57,180 sh across 3 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $770K
57,180 sh across 3 lots
Exec Mar 19
Filed Mar 23 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $762K
57,180 sh across 3 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $2.3M
174,303 sh across 4 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.2M
81,342 sh across 3 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.5M
92,823 sh across 4 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $416K
59,505 sh across 2 lots
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET